Announcements Trials

Browse Landscape

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 40 HER2 Positive Metastatic Breast Cancer 4 Breast Diseases 4 Brain Neoplasms 4 Carcinoma, Non-Small-Cell Lung 3 Stomach Neoplasms 2 HER2-positive Breast Cancer 2 Colorectal Neoplasms 2 Advanced Breast Cancer 2 Triple Negative Breast Neoplasms 1 Solid Tumor 1 Salivary Gland Neoplasms 1 Pathologic Complete Response 1 Neoplasm Metastasis 1 Neoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer 1 HER2-positive Metastatic Breast Cancer 1 HER2+ Early or Locally Advanced Breast Cancer 1 HER2+ Breast Cancer 1 HER2 Positive Gastric Cancer 1 HER2 Positive Breast Cancer 1 HER-2 Positive Colorectal Cancer 1 Estrogen Receptor-positive Breast Cancer 1 Digestive System Neoplasms 1 Carcinoma, Transitional Cell 1

Interventions

Cisplatin 3 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Paclitaxel 2 temoporfin 1 pyrotinib 1 fluoromisonidazole 1 bicalutamide 1 Rubidium-82 1 Ritonavir 1 Radiotherapy, Conformal 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Liquid Biopsy 1 Leuprolide 1 Ipilimumab 1 Indinavir 1 Gemcitabine 1 Fluorodeoxyglucose F18 1 Enzyme-Linked Immunosorbent Assay 1 Docetaxel 1 Chemotherapy, Adjuvant 1 Carboplatin 1 CTLA-4 Antigen 1 Brachytherapy 1 Amifostine 1 5-fluoropentyl-2-methylmalonic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Salivary Gland Neoplasms × pyrotinib × Clear all

NCT05087706 2021-10-21

MAPS

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡